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overall they are of high standard. Although the
authors mention in the preface the concerns
regarding the late complications of therapy, these
are discussed to a very variable extent in different
tumour groups and are not mentioned at all in the
discussions on soft tissue sarcomas and Ewing's
tumour-two tumours where particularly serious
problems have been encountered. The final chapter
discusses the nutritional consequences of cancer
therapy and parentral nutrition-it is a good
introduction to an area which is expanding rapidly
due to better understanding and greater need
during intensive chemotherapy programmes.
This is an excellent book, the strength of which
lies in the fact that it is really a mammoth unbiased
review of the current state of the art and science of
paediatric oncology. The authors have produced an
extensive bibliography which is commendable for
its current references. They have presented a
balanced and honest text which is very easy to read
and allows the reader to assess different approaches
without bias. I would recommend it to anyone
working in the field.
P. Morris-Jones,
Dept. Child Health,
Royal Manchester Children's Hospital,
Pendlebury,
Manchester
Cancer: The Biology of Malignant Disease. G.
CURRIE & A. CURRIE, UK, Edward Arnold, 135 pp,
1982, £6.95, ISBN 0 7131 4400 9.
The authors have presented a coherent discussion
of cancer as a disease process involving different
hierarchical levels of organisation. Individual
chapters deal with cancer as seen in terms of
populations, individuals, organs, tissues, cells and
"molecular biology". The result is an eminently
readable text which is notable for its broad scope
and intelligent synthesis of divergent data. A
particularly laudable feature of the book is the
manner in which the authors have integrated their
discussion of the clinical aspects of cancer with a
clear account of information derived from basic
scientific research. The chapter on the epidemiology
of cancer gives an introductory account of this
discipline and, more importantly, puts the following
chapters into a more global perspective. There are
clear accounts given in the succeeding chapters
concerning carcinogenesis, tumour-host
interactions, local invasion and metastasis, and cell
cycle, events. The final chapter gives a concise
account of current treatment modalities and
presents a number of speculations regarding future
modes of therapy. I believe that this text will be of
great interest to medical students and research
scientists alike, since it provides an insight into
current thoughts concerning the underlying
mechanisms responsible for the altered behaviour of
neoplastic cells, as well as the behaviour of the
"real" tumours encountered by clinicians in their
daily practice. The only reservation I have
regarding the text is that I feel the authors have
been a bit too sparing regarding the number of
references cited for further information at the end
of each chapter. I believe that additional references
would have allowed readers to follow up points
raised in the text without making it unduly
cumbersome as an introductory text.
S. Schor,
Dept. Medical Oncology,
Christie Hospital & Holt Radium Institute,
Manchester
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It will soon be 30 years since the toxic and then the
carcinogenic properties of dimethylnitrosamine
attracted scientific attention. The possible hazards
to man from the nitroso compounds led to a
remarkable explosion of scientific endeavour
covering environmental, fundamental and
epidemiological aspects of the problem. In some
wvays, therefore, it is surprising to see that a
definitive answer to the question of carcinogenicity
to man still remains elusive, but in view of the wide
variety of low-level exogenous and endogenous
environmental sources of exposure and ways in
which the pharmacokinetics of nitrosamines may be
modified, the problem may be with us for some
while yet.
There is no doubt about the high toxicity of
agents such as demethylnitrosamine as the
pathology reports given in this volume explain and
there is now a wealth of information on toxicity
and carcinogenicity in experimental systems. Well
over a 100 nitrosocompounds have been shown to
be carcinogenic, covering 5 major groups (Classes)
of animals and including at least 6 species of
primate. It is evident that they are very powerful
experimental tools for use in understanding
mechanisms in carcinogenesis, particularly in view
of their remarkable organ-specificity. The influence
of alcohol as a modifying factor in nitrosamine-
induced carcinogenesis clearly emerged from this
symposium and it is interesting to see the